1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Trabedersen: new trials by email Literature Review of Trabedersen trials Research Report on Trabedersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma trabedersen, temozolomide, Drug delivery system for administration of AP 12009 - Anaplastic Astrocytoma, Glioblastoma | Phase 3 | Terminated | Isarna Therapeutics GmbH | 27 | 2008-12-01 | 2014-11-14 |
Astrocytoma (1) · Brain Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Neoplasms (1)
Argentina (1) · Austria (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Mexico (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)